Category : Search result: Congress government drugs


Himachal Leads Nation in Substandard Drugs: 49 Fail

Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.

Himachal Congress to be reconstituted in 3 months

Himachal Pradesh Congress chief Vinay Kumar announces a major organizational overhaul within three months, pledging to address senior leaders' concerns for party unity. Read the full story.

Congress MLA Claims Liquor, Drugs Rampant in Gujarat

Congress MLA Jignesh Mevani alleges liquor, drugs, prostitution, and gambling are freely available across Gujarat's 33 districts, challenging the state's dry status. Read the shocking revelations.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

Congress Issues Notices to 43 Bihar Leaders

Congress disciplinary committee takes action against 43 Bihar leaders for anti-party activities. Leaders must submit written clarification by November 21. Party faces worst electoral performance in recent history.

Congress Delays Karnataka Leadership Decisions

As internal power struggles intensify within Karnataka Congress, the party's central leadership delays key decisions on state appointments. Siddaramaiah and D.K. Shivakumar remain central figures in the ongoing political drama.

AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion

British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.

Rahul Gandhi: Instagram Reels are Digital Drugs

Congress leader Rahul Gandhi launches scathing attack on PM Modi, comparing Instagram Reels to digital drugs and criticizing cheap data policies for creating addiction among Indian youth.

Trump's $149 Weight-Loss Drug Deal with Ozempic Maker

Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.

Page 2 of 4